ResearcherUniversitätsmedizin RostockActive in the last 2 years
Tim Schreiber
Matched on OpenAlex author ID A5062599493. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 11
2022: 1 paper · 2023: none · 2024: 2 papers · 2025: 1 paper · 2026: 1 paper
Papers 5
- Targeting pancreatic cancer with combined inhibition of EGFR and RAF. Co-author DOI 10.1371/journal.pone.0347843↗
- Burrowing Behavior as Robust Parameter for Early Humane Endpoint Determination in Murine Models for Pancreatic Cancer. Co-author DOI 10.3390/ani15091241↗
- Evidence-Based Severity Assessment of Animal Models for Pancreatic Cancer. Co-author DOI 10.3390/biomedicines12071494↗
- Sex Matters-Insights from Testing Drug Efficacy in an Animal Model of Pancreatic Cancer. Co-author DOI 10.3390/cancers16101901↗
- Targeting pancreatic cancer with combinatorial treatment of CPI-613 and inhibitors of lactate metabolism. First author DOI 10.1371/journal.pone.0266601↗
Closest collaborators
The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Brigitte Vollmar · 5 shared papers, 2022–2026 · strength 1.08
- Paper Targeting pancreatic cancer with combined inhibition of EGFR and RAF. DOI 10.1371/journal.pone.0347843↗
- Paper Burrowing Behavior as Robust Parameter for Early Humane Endpoint Determination in Murine Models for Pancreatic Cancer. DOI 10.3390/ani15091241↗
- Paper Sex Matters-Insights from Testing Drug Efficacy in an Animal Model of Pancreatic Cancer. DOI 10.3390/cancers16101901↗
- Simone Kumstel · 4 shared papers, 2022–2026 · strength 0.88
- Paper Targeting pancreatic cancer with combined inhibition of EGFR and RAF. DOI 10.1371/journal.pone.0347843↗
- Paper Burrowing Behavior as Robust Parameter for Early Humane Endpoint Determination in Murine Models for Pancreatic Cancer. DOI 10.3390/ani15091241↗
- Paper Evidence-Based Severity Assessment of Animal Models for Pancreatic Cancer. DOI 10.3390/biomedicines12071494↗
- Dietmar Zechner · 4 shared papers, 2022–2025 · strength 0.78
- Paper Burrowing Behavior as Robust Parameter for Early Humane Endpoint Determination in Murine Models for Pancreatic Cancer. DOI 10.3390/ani15091241↗
- Paper Sex Matters-Insights from Testing Drug Efficacy in an Animal Model of Pancreatic Cancer. DOI 10.3390/cancers16101901↗
- Paper Evidence-Based Severity Assessment of Animal Models for Pancreatic Cancer. DOI 10.3390/biomedicines12071494↗
- Jakob Brandstetter · 3 shared papers, 2024–2026 · strength 0.74
- Paper Targeting pancreatic cancer with combined inhibition of EGFR and RAF. DOI 10.1371/journal.pone.0347843↗
- Paper Burrowing Behavior as Robust Parameter for Early Humane Endpoint Determination in Murine Models for Pancreatic Cancer. DOI 10.3390/ani15091241↗
- Paper Evidence-Based Severity Assessment of Animal Models for Pancreatic Cancer. DOI 10.3390/biomedicines12071494↗
- Benjamin Schulz · 2 shared papers, 2024–2025 · strength 0.45
- Yixuan Ma · 1 shared paper, 2024 · strength 0.20
- Hugo Murua Escobar · 1 shared paper, 2024 · strength 0.20
- Robert Jaster · 1 shared paper, 2024 · strength 0.18
- Edgar Heinz Uwe Wendt · 1 shared paper, 2022 · strength 0.14
- Maria Schönrogge · 1 shared paper, 2022 · strength 0.14
- Xianbin Zhang · 1 shared paper, 2022 · strength 0.14
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.